Lühnsdorf Bork, Epe Bernd, Khobta Andriy
From the Institute of Pharmacy and Biochemistry, Johannes Gutenberg University of Mainz, Staudingerweg 5, 55128 Mainz, Germany.
From the Institute of Pharmacy and Biochemistry, Johannes Gutenberg University of Mainz, Staudingerweg 5, 55128 Mainz, Germany
J Biol Chem. 2014 Aug 8;289(32):22008-18. doi: 10.1074/jbc.M113.521807. Epub 2014 Jun 20.
Uracil is an unavoidable aberrant base in DNA, the repair of which takes place by a highly efficient base excision repair mechanism. The removal of uracil from the genome requires a succession of intermediate products, including an abasic site and a single strand break, before the original DNA structure can be reconstituted. These repair intermediates are harmful for DNA replication and also interfere with transcription under cell-free conditions. However, their relevance for cellular transcription has not been proved. Here we investigated the influence of uracil incorporated into a reporter vector on gene expression in human cells. The expression constructs contained a single uracil opposite an adenine (to mimic dUTP misincorporation during DNA synthesis) or a guanine (imitating a product of spontaneous cytosine deamination). We found no evidence for a direct transcription arrest by uracil in either of the two settings because the vectors containing the base modification exhibited unaltered levels of enhanced GFP reporter gene expression at early times after delivery to cells. However, the gene expression showed a progressive decline during subsequent hours. In the case of U:A pairs, this effect was retarded significantly by knockdown of UNG1/2 but not by knockdown of SMUG1 or thymine-DNA glycosylase uracil-DNA glycosylases, proving that it is base excision by UNG1/2 that perturbs transcription of the affected gene. By contrast, the decline of expression of the U:G constructs was not influenced by either UNG1/2, SMUG1, or thymine-DNA glycosylase knockdown, strongly suggesting that there are substantial mechanistic or kinetic differences between the processing of U:A and U:G lesions in cells.
尿嘧啶是DNA中不可避免的异常碱基,其修复通过高效的碱基切除修复机制进行。在原始DNA结构得以重建之前,从基因组中去除尿嘧啶需要一系列中间产物,包括一个无碱基位点和一个单链断裂。这些修复中间体对DNA复制有害,在无细胞条件下也会干扰转录。然而,它们与细胞转录的相关性尚未得到证实。在此,我们研究了掺入报告载体中的尿嘧啶对人类细胞基因表达的影响。表达构建体在腺嘌呤对面含有单个尿嘧啶(以模拟DNA合成过程中dUTP的错误掺入)或鸟嘌呤(模拟胞嘧啶自发脱氨的产物)。我们没有发现证据表明在这两种情况下尿嘧啶会直接导致转录停滞,因为在递送至细胞后的早期,含有碱基修饰的载体中增强型绿色荧光蛋白报告基因的表达水平未发生改变。然而,在随后的数小时内,基因表达呈逐渐下降趋势。对于U:A配对的情况,通过敲低UNG1/2可显著延缓这种效应,但敲低SMUG1或胸腺嘧啶-DNA糖基化酶尿嘧啶-DNA糖基化酶则不能,这证明是UNG1/2进行的碱基切除扰乱了受影响基因的转录。相比之下,U:G构建体表达的下降不受UNG1/2、SMUG1或胸腺嘧啶-DNA糖基化酶敲低的影响,这强烈表明细胞中U:A和U:G损伤处理过程在机制或动力学上存在实质性差异。